Disease: LGMD2J
| Position | Domain | Domain position | SNV | RS | Source | Comments | MAF | Zygosity | Structural Position | AlphaMissense (IC) | REVEL | Rhapsody | DUET | PolyPhen-2 | Condel | Q(SASA) |
Site annotation |
mCSM PPI |
Predicted PPI site |
AFR | AMR | EAS | EUR | FIN | NFE | SAS |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
35930  |
Ig-169 |
34 | W/R | rs1018591024  |
Zheng (2016)
| WES prioritisation of single 5-generation CN family; co-segregation within family (recessive inheritance, n = 3, 3 affected, (6 total)) | None | hom | 48 |
0.9987 | 0.938 | 0.836 | -2.172 | 1.0 | None | 0.1526 | None | -0.843(OBSL1) -1.308(OBSCN) | N | None | None | None | None | None | None | None | 35930 |
Ig-169 |
34 | W/R | rs1018591024 |
gnomAD-4.0.0 | None | 0.0000027366 | None | 48 |
0.9987 | 0.938 | 0.836 | -2.172 | 1.0 | None | 0.1526 | None | -0.843(OBSL1) -1.308(OBSCN) | N | 0 | 0 | 0 | None | 0 | 3.59762E-06 | 0 | 35946 |
Ig-169 |
50 | H/P | rs281864931 |
Pollazzon (2010)
Rudloff (2015)
| Genetic analysis of TTN in single 3-generation ITA family; co-segregates with disease (n = 5, 5 affected (total 7)); Domain unfolds at body temperature; eliminates binding to OBSCN-Ig1; low expression; monomeric | None | het | 122 |
0.7767 | 0.628 | 0.721 | -0.76 | 0.998 | None | 0.2633 | None | -1.036(OBSL1) -0.709(OBSCN) | N | None | None | None | None | None | None | None | 35947 |
Ig-169 |
51 | I/N | None | gnomAD-2.1.1 | None | 0.00000401 | None | 123 |
0.7303 | 0.652 | 0.701 | -1.845 | 0.901 | None | 0.1542 | None | -0.949(OBSL1) -0.17(OBSCN) | N | 0 | 0 | 0 | None | 0 | 0 | 8.85E-06 | 35947 |
Ig-169 |
51 | I/N | None | gnomAD-3.1.2 | None | 0.0000131 | None | 123 |
0.7303 | 0.652 | 0.701 | -1.845 | 0.901 | None | 0.1542 | None | -0.949(OBSL1) -0.17(OBSCN) | N | 0 | 0 | 0 | None | 0 | 2.94E-05 | 0 | 35947 |
Ig-169 |
51 | I/N | None |
Van den Bergh (2003)
Rudloff (2015)
Evila (2016)
| Genetic analysis of TTN in 3-generation BEL family with TMD, incomplete penetrance (n = 6, 5 affected, 1 unaffected carrier (total 9)); Genetic analysis of genes in 10 TMD families; co-segregation in 2-generation family (recessive inheritance, n = 2, 1 affected (total 3; disease state only where compound heterozygous for both I35947N and Q22507*));variant prioritisation; comp het with Q22507*; No significant difference in domain stability; does not affect binding to OBSCN-Ig1; normal expression; monomeric | None | het / comp het with Q22507* | 123 |
0.7303 | 0.652 | 0.701 | -1.845 | 0.901 | None | 0.1542 | None | -0.949(OBSL1) -0.17(OBSCN) | N | None | None | None | None | None | None | None | 35947 |
Ig-169 |
51 | I/N | None | gnomAD-4.0.0 | None | 0.0000111535 | None | 123 |
0.7303 | 0.652 | 0.701 | -1.845 | 0.901 | None | 0.1542 | None | -0.949(OBSL1) -0.17(OBSCN) | N | 0 | 0 | 0 | None | 0 | 1.52557E-05 | 0 | 35956 |
Ig-169 |
60 | L/P | rs267607156 |
Hackman (2002)
Rudloff (2015)
| Genetic analysis of single FRA family; co-segregates within family (n = 3, 3 affected (7 total)); Severe misfolding of domain; eliminates binding to OBSCN-Ig1; low expression; monomeric | None | het | 138 |
0.999 | 0.788 | 0.895 | -1.745 | 1.0 | None | 0.1078 | None | -0.747(OBSL1) -0.71(OBSCN) | N | None | None | None | None | None | None | None |